Suppr超能文献

镰状细胞贫血患者的血液学参数与预后的关系

Hematological parameters in association with outcomes in sickle cell anemia patients.

作者信息

Emmanuelchide Okocha, Charle Odenigbo, Uchenna Okonkwo

机构信息

Department of Hematology, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Anambra State, Nigeria.

出版信息

Indian J Med Sci. 2011 Sep;65(9):393-8.

Abstract

INTRODUCTION

Sickle cell disease (SCD) has a wide range of clinical presentation. We evaluated hematological parameters, which are widely evaluable and assessable, as indices of clinical outcome in SCD. These parameters, although largely established as indices of clinical outcome in other SCD populations, have not been widely evaluated in African patients.

MATERIALS AND METHODS

One hundred and thirty six consecutive stable SCD patients who presented in the sickle cell clinic of a teaching hospital were studied retrospectively using a questionnaire. Hematological parameters of full blood count (FBC) for each patient were obtained using a cell counter. FBC parameters such as White blood cell count (WBC) were then statistically correlated with complications such as ankle ulcers, osteomylitis and others. A Chi-square text was used to compare frequencies and generate P values.

RESULTS

The presence of sickle cell complications was significantly associated with raised white blood cell count (WBC) above 11 × 10(9)/l (P = 0.03).The WBC of the patients increased with increasing numbers of complications (P = 0.07). Mean packed cell volume (PCV) and WBC tended toward the reference range for age and sex (in apparently normal individuals) as the age at diagnosis of SCD increased. This trend was significant for PCV (P = 0.01).

CONCLUSION

Our data provide additional support that widely evaluable and assessable hematological parameters such as PCV and WBC can be used as indices to predict SCD outcome in African patients. This is likely to impart positively on individualized therapy.

摘要

引言

镰状细胞病(SCD)具有广泛的临床表现。我们评估了血液学参数,这些参数易于评估和测定,作为SCD临床结局的指标。这些参数虽然在很大程度上已被确立为其他SCD人群临床结局的指标,但在非洲患者中尚未得到广泛评估。

材料与方法

回顾性研究了在一家教学医院的镰状细胞门诊就诊的136例连续稳定的SCD患者,使用问卷调查。使用血细胞计数器获取每位患者全血细胞计数(FBC)的血液学参数。然后将FBC参数如白细胞计数(WBC)与诸如踝部溃疡、骨髓炎等并发症进行统计学关联。使用卡方检验比较频率并生成P值。

结果

镰状细胞并发症的存在与白细胞计数(WBC)高于11×10⁹/L显著相关(P = 0.03)。患者的WBC随着并发症数量的增加而升高(P = 0.07)。随着SCD诊断年龄的增加,平均红细胞压积(PCV)和WBC趋向于年龄和性别的参考范围(在明显正常个体中)。这种趋势在PCV方面具有显著性(P = 0.01)。

结论

我们的数据提供了额外的支持,即诸如PCV和WBC等易于评估和测定的血液学参数可作为预测非洲患者SCD结局的指标。这可能对个体化治疗产生积极影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验